- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/08 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing alicyclic rings
Patent holdings for IPC class C07D 403/08
Total number of patents in this class: 333
10-year publication summary
|
13
|
19
|
28
|
27
|
17
|
20
|
13
|
28
|
23
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 164 |
24 |
| Assembly Biosciences, Inc. | 77 |
14 |
| Merck Sharp & Dohme LLC | 3742 |
9 |
| Boehringer Ingelheim International GmbH | 4644 |
7 |
| Merck Patent GmbH | 5818 |
7 |
| Epizyme, Inc. | 373 |
7 |
| Incyte Corporation | 1025 |
7 |
| Janssen Pharmaceutica N.V. | 3384 |
6 |
| Gilead Sciences, Inc. | 2038 |
6 |
| F. Hoffmann-La Roche AG | 7920 |
5 |
| Nippon Chemiphar Co., Ltd. | 229 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2856 |
5 |
| VisEn Medical, Inc. | 72 |
5 |
| Bristol-myers Squibb Company | 4884 |
4 |
| Vertex Pharmaceuticals Incorporated | 1595 |
4 |
| Incyte Holdings Corporation | 661 |
4 |
| Taro Pharmaceuticals Inc. | 34 |
4 |
| The Regents of the University of California | 19943 |
3 |
| Cytokinetics, Inc. | 278 |
3 |
| Dyomics GmbH | 19 |
3 |
| Other owners | 201 |